Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Edwin Singer, M.D.


This page shows the publications co-authored by Daniel Singer and Samuel Goldhaber.
Connection Strength

  1. Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study. J Thromb Thrombolysis. 2022 Feb; 53(2):399-409.
    View in: PubMed
    Score: 0.239
  2. Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study. Semin Thromb Hemost. 2021 May 10.
    View in: PubMed
    Score: 0.234
  3. Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study. J Thromb Thrombolysis. 2021 Apr; 51(3):561-570.
    View in: PubMed
    Score: 0.232
  4. Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study. Am J Med. 2020 08; 133(8):936-945.
    View in: PubMed
    Score: 0.217
  5. NOACs for treatment of venous thromboembolism in clinical practice. Thromb Haemost. 2017 06 28; 117(7):1317-1325.
    View in: PubMed
    Score: 0.177
  6. RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate. Thromb Haemost. 2017 01 26; 117(2):415-421.
    View in: PubMed
    Score: 0.172
  7. Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillation. Am Heart J. 2009 Jun; 157(6):1064-73.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.